Annual Results Results Snapshot
Figures in Rs cr
Standalone Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is 26.33% vs 23.72% in Mar 2023
Standalone Net Profit
YoY Growth in year ended Mar 2024 is 44.50% vs 70.50% in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is 31.42% vs 91.83% in Mar 2023
Interest
YoY Growth in year ended Mar 2024 is 47.09% vs 98.72% in Mar 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2024 has improved from Mar 2023
Compare Annual Results Of Fredun Pharma With
Figures in Rs cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
346.58
8,558.51
-8,211.93
-95.95%
Other Operating Income
2.49
0.00
2.49
Total Operating income
349.07
8,558.51
-8,209.44
-95.92%
Raw Material Cost
283.76
859.11
-575.35
-66.97%
Purchase of Finished goods
0.00
1,825.86
-1,825.86
-100.00%
(Increase) / Decrease In Stocks
-22.44
-60.74
38.30
63.06%
Employee Cost
12.50
1,890.84
-1,878.34
-99.34%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
13.62
0.00
13.62
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
22.73
1,859.00
-1,836.27
-98.78%
Total Expenditure (Excl Depreciation)
310.17
6,374.07
-6,063.90
-95.13%
Operating Profit (PBDIT) excl Other Income
38.90
2,184.44
-2,145.54
-98.22%
Other Income
0.00
266.64
-266.64
-100.00%
Operating Profit (PBDIT)
38.90
2,451.08
-2,412.18
-98.41%
Interest
13.65
14.57
-0.92
-6.31%
Exceptional Items
0.00
103.53
-103.53
-100.00%
Gross Profit (PBDT)
25.25
2,436.51
-2,411.26
-98.96%
Depreciation
3.80
317.46
-313.66
-98.80%
Profit Before Tax
21.45
2,119.05
-2,097.60
-98.99%
Tax
5.83
399.17
-393.34
-98.54%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
15.62
1,719.88
-1,704.26
-99.09%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
103.53
-103.53
-100.00%
Net Profit
15.62
1,823.41
-1,807.79
-99.14%
Equity Capital
4.70
40.06
-35.36
-88.27%
Face Value
10.00
1.00
0.00
Reserves
116.77
9,583.75
-9,466.98
-98.78%
Earnings per share (EPS)
33.23
45.52
-12.29
-27.00%
Diluted Earnings per share
33.32
45.45
-12.13
-26.69%
Operating Profit Margin (Excl OI)
11.22%
25.52%
0.00
-14.30%
Gross Profit Margin
7.29%
28.47%
0.00
-21.18%
PAT Margin
4.51%
20.10%
0.00
-15.59%
Public Share Holdings (%)
50.84%
0.00%
50.84
50.84%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 346.58 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 26.33% vs 23.72% in Mar 2023
Annual - Standalone Net Profit
Standalone Net Profit 15.62 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 44.50% vs 70.50% in Mar 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 38.90 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 31.42% vs 91.83% in Mar 2023
Annual - Interest
Interest 13.65 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 47.09% vs 98.72% in Mar 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.22%
in Mar 2024Figures in Rs %
YoY Growth in year ended Mar 2024 has improved from Mar 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
